Coronavirus disease 2019 (COVID-19) : frequently asked questions
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Coronavirus disease 2019 (COVID-19) : frequently asked questions

Filetype[PDF-216.07 KB]


Details:
    1. Filetype[PDF - 65.84 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (COVID-19)
      Description:
      There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present clinical manage...
      File Type:
      Filetype[PDF - 65.84 KB]
      File Type:
      Filetype[PDF - 65.84 KB]
    2. Filetype[PDF - 517.96 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 20, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      Updated March 20, 2020This page will be updated regularly at noon Mondays through Fridays. Numbers close out at 4 p.m. the day before reporting.CDC is...
      File Type:
      Filetype[PDF - 517.96 KB]
      File Type:
      Filetype[PDF - 517.96 KB]
    3. Filetype[PDF - 542.80 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 20, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.CDC is responding to an outbrea...
      File Type:
      Filetype[PDF - 542.80 KB]
      File Type:
      Filetype[PDF - 542.80 KB]
    4. Filetype[PDF - 539.17 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 539.17 KB]
      File Type:
      Filetype[PDF - 539.17 KB]
    5. Filetype[PDF - 832.93 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      18//03/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Vietnamese]CDC Ä‘ang quyêÌt liệt Æ°Ìng phoÌ vÆ¡Ìi sÆ°Ì£ buÌ€ng phaÌt toaÌ€n cầu của COVID-19 vaÌ...
      File Type:
      Filetype[PDF - 832.93 KB]
      File Type:
      Filetype[PDF - 832.93 KB]
    6. Filetype[PDF - 822.75 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Spanish]Los CDC estaÌn respondiendo eneÌrgicamente al brote mundial de COVID-19 y su propagacioÌn comunitari...
      File Type:
      Filetype[PDF - 822.75 KB]
      File Type:
      Filetype[PDF - 822.75 KB]
    7. Filetype[PDF - 884.64 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Chinese]CDC正在积æžåº”对全çƒCOVID-19的爆å‘以åŠç¾Žå›½å¢ƒå†…的社区传播。cdc.gov/COVID19CS 31545...
      File Type:
      Filetype[PDF - 884.64 KB]
      File Type:
      Filetype[PDF - 884.64 KB]
    8. Filetype[PDF - 835.13 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC protects and prepares communities [Korean]CDC is aggressively responding to the global outbreak of COVID-19 and community spread in the U.S. [Kore...
      File Type:
      Filetype[PDF - 835.13 KB]
      File Type:
      Filetype[PDF - 835.13 KB]
    9. Filetype[PDF - 224.26 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 20, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      File Type:
      Filetype[PDF - 224.26 KB]
      File Type:
      Filetype[PDF - 224.26 KB]
    10. Filetype[PDF - 813.54 KB]
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.)
      Published Date:
      03/18/2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      CDC is aggressively responding to the global outbreak of COVID-19 and community spread in the U.S.cdc.gov/COVID19CS 315454-Ainfographic-cdc-protects-5...
      File Type:
      Filetype[PDF - 813.54 KB]
      File Type:
      Filetype[PDF - 813.54 KB]
    11. Filetype[PDF - 346.12 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (COVID-19)
      Description:
      This is an emerging, rapidly evolving situation and CDC will provide updated information as it becomes available, in addition to updated guidance.Upda...
      File Type:
      Filetype[PDF - 346.12 KB]
      File Type:
      Filetype[PDF - 346.12 KB]
    12. Filetype[PDF - 539.17 KB]
      Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
      Published Date:
      March 21, 2020
      Series:
      Coronavirus Disease 2019 (CoVID-19)
      Description:
      This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.CDC is responding to an outbrea...
      File Type:
      Filetype[PDF - 539.17 KB]
      File Type:
      Filetype[PDF - 539.17 KB]
    13. Filetype[PDF - 170.47 KB]
      Corporate Authors:
      United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. ; SRC, Inc. ;
      Published Date:
      February 2020
      Series:
      ToxFAQs
      Description:
      2-Hexanone is also known as methyl n-butyl ketone, MBK, or propyl acetone. It is a clear, colorless liquid with a sharp odor. It dissolves very easily...
      File Type:
      Filetype[PDF - 170.47 KB]
      File Type:
      Filetype[PDF - 170.47 KB]
    14. Filetype[PDF - 178.71 KB]
      Corporate Authors:
      United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. ; SRC, Inc. ;
      Published Date:
      Septiembre 1995
      Series:
      ToxFAQs
      Description:
      2-Hexanone - ToxFAQs [Spanish]La 2-hexanona se conoce también como metil n-butil cetona (MBK) o propil acetona. Es un líquido incoloro de aroma pene...
      File Type:
      Filetype[PDF - 178.71 KB]
      File Type:
      Filetype[PDF - 178.71 KB]

You May Also Like:

  1. Filetype[PDF - 597.12 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 16, 2021
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated July 16, 2021
    File Type:
    Filetype[PDF - 597.12 KB]
    File Type:
    Filetype[PDF - 597.12 KB]
  2. Filetype[PDF - 331.78 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Mar 17, 2021
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated Mar. 17, 2021
    File Type:
    Filetype[PDF - 331.78 KB]
    File Type:
    Filetype[PDF - 331.78 KB]
  3. Filetype[PDF - 187.23 KB]
    Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Diabetes Translation.
    Published Date:
    Feb. 10, 2021
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated Feb. 10, 2021This interim guidance has been updated based on currently available information about COVID-19 and the current situation in the U...
    File Type:
    Filetype[PDF - 187.23 KB]
    File Type:
    Filetype[PDF - 187.23 KB]
  4. Filetype[PDF - 321.97 KB]
    Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Diabetes Translation.
    Published Date:
    April 3, 2020
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Audience: These considerations are intended for use by federal, state, and local public health officials, respiratory protection program managers, lea...
    File Type:
    Filetype[PDF - 321.97 KB]
    File Type:
    Filetype[PDF - 321.97 KB]
  5. Filetype[PDF - 2.57 MB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 9, 2021
    Series:
    Coronavirus Disease 2019 (CoVID-19)
    Description:
    Updated July 9, 2021
    File Type:
    Filetype[PDF - 2.57 MB]
    File Type:
    Filetype[PDF - 2.57 MB]